Chemoprevention of intestinal adenomas in the Apc(Min) mouse by piroxicam: Kinetics, strain effects and resistance to chemosuppression

Carcinogenesis

Volumn 20, Issue 1, 1999, Pages 51-58

  Ritland, Steve R ^a   Gendler, Sandra J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CHEMOSENSITIVITY; CHROMOSOME DELETION; CONTROLLED STUDY; INTESTINE TUMOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR REGRESSION;

ADENOMA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; APOPTOSIS; COLONIC NEOPLASMS; CROSSES, GENETIC; CYCLOOXYGENASE INHIBITORS; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DUODENAL NEOPLASMS; FEMALE; GENES, APC; GENETIC PREDISPOSITION TO DISEASE; INTESTINAL DISEASES; INTESTINAL NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PIROXICAM; ULCER;

EID: 0032897353     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.1.51     Document Type: Article

References (37)

1. Sporn, M.B. and Roberts, A.B. (1984) Role of retinoids in differentiation and carcinogenesis. J. Natl Cancer Inst., 73, 1381-1387.
2. Lippman, S.M., Benner, S.E. and Hong, W.K. (1994) Cancer chemoprevention. J. Clin. Oncol., 12, 851-873.
3. Szarka, C.E., Grana, G. and Engstrom, P.F. (1994) Chemoprevention of cancer. Curr. Prob. Cancer, 18, 6-79.
4. Giardiello, F.M., Offerhaus, G.J. and DuBois, R.N. (1995) The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer, 31A, 1071-1076.
5. DuBois, R.N., Giardiello, F.M. and Smalley, W.E. (1996) Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol. Clin. N. Am., 25, 773-791.
6. Marnett, L.J. and Honn, K.V. (1994) Overview of articles on eicosanoids and cancer. Cancer Metastasis Rev., 13, 237-239.
7. Prescott, S.M. and White, R.L. (1996) Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell, 87, 783-786.
8. Smith, W.L. and DeWitt, D.L. (1995) Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Sem. Nephrol., 15, 179-194.
9. Eberhart, C.E. and Dubois, R.N. (1995) Eicosanoids and the gastrointestinal tract. Gastroenterology, 109, 285-301.
10. Earnest, D.L., Hixson, L.J. and Alberts, D.S. (1992) Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J. Cell. Biochem., 161 (suppl.), 156-166.
11. Lupulescu, A. (1996) Prostaglandins, their inhibitors and cancer. Prostaglandins Leuk. Ess. Fatty Acids, 54, 83-94.
12. Williams, C.S., Luongo, C., Radhika, A., Zhang, T., Lamps, L.W., Nanney, L.B., Beauchamp, R.D. and DuBois, R.N. (1996) Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111, 1134-1140.
13. Sano, H., Kawahito, Y., Wilder, R.L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla, T. (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789.
14. Oshima, M., Dinchuk, J.E., Kargman, S.L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J.M., Evans, J.F. and Taketo, M.M. (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
15. Boolbol, S.K., Dannenberg, A.J., Chadburn, A. et al. (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56, 2556-2560.
16. Sheng, H., Shao, J., Kirkland, S.C., Isakson, R., Coffey, R.J., Morrow, J., Beauchamp, R.D. and DuBois, R.N. (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99, 2254-2259.
17. Krishnan, K. and Brenner, D.E. (1996) Chemoprevention of colorectal cancer. Gast. Clin. N. Am., 25, 821-858.
18. Takahashi, M., Fukutake, M., Yokota, S., Ishida, K., Wakabayashi, K. and Sugimura, T. (1996) Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. J. Cancer Res. Clin. Oncol., 122, 219-222.
19. Reddy, B.S., Rao, C.V. and Seibert, K. (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56, 4566-4569.
20. Ladenheim, J., Garcia, G., Titzer, D., Herzenberg, H., Lavori, P., Edson, R. and Omary, M.B. (1995) Effect of sulindac on sporadic colonic polyps. Gastroenterology, 108, 1083-1087.
21. Niv, Y. and Fraser, G.M. (1994) Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology, 107, 854-857.
22. Trujillo, M.A., Garewal, H.S. and Sampliner, R.E. (1994) Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer. At what cost? Dig. Dis. Sci., 39, 2260-2266.
23. Moser, A.R., Pitot, H.C. and Dove, W.F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
24. Su, L.K., Kinzler, K.W., Vogelstein, B., Preisinger, A.C., Moser, A.R., Luongo, C., Gould, K.A. and Dove, W.F. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668-670.
25. Jacoby, R.F., Marshall, D.J., Newton, M.A. et al. (1996) Chemoprevention of spontaneous intestinal adenomas in the Ape Min mouse model by the nonsteroidal anti-inflammatory drag piroxicam. Cancer Res., 56, 710-714.
26. Lyon, M.F., Sohalia R. and Brown, S.D.M. (1995) Genetic Variants and Strains of the Laboratory Mouse. Oxford University Press, New York, NY.
27. Ritland, S.R., Rowse, G.R., Chang, Y. and Gendler, S.J. (1997) Loss of heterozygosity analysis in primary mammary tumors and lung metastasis of MMTV-MTAg and MMTV-neu transgenic mice. Cancer Res., 57, 3520-3525.
28. Chiu, C.-H., McEntee, M.F. and Whelan, J. (1997) Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Res., 57, 4267-4273.
29. Shiff, S.J., Koutsos, M.I., Qiao, L. and Rigas, B. (1996) Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res., 222, 179-188.
30. Cohn, S.M., Simon, T.C., Roth, K.A., Birkenmeier, E.H. and Gordon, J.I. (1992) Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional patterns of expression along the duodenal-colonic and cryptvillus axes of the gut epithelium. J. Cell Biol., 119, 27-44.
31. Dove, W.F., Gould, K.A., Luongo, C., Moser, A.R. and Shoemaker, A.R. (1995) Emergent issues in the genetics of intestinal neoplasia. Cancer Surveys, 25, 335-355.
32. Shoemaker, A.R., Gould, K.A., Luongo, C., Moser, A.R. and Dove, W.F. (1997) Studies of neoplasia in the Min mouse. Biochem. Biophys. Acta, 1332, F25-F48.
33. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C. and Taketo, M. (1995) Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl Acad. Sci. USA, 92, 4482-4486.
34. Sandler, R.S. (1996) Aspirin and Other Nonsteroidal Anti-inflammatory Agents in the Prevention of Colorectal Cancer. Important Advances in Oncology. Lippencott-Raven Press, Philadelphia, PA.
35. Dietrich, W.F., Lander, E.S., Smith, J.S., Moser, A.R., Gould, K.A., Luongo, C., Borenstein, N. and Dove, W. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, 75, 631-639.
36. Liu, T., Mokuolu, A.O., Rao, C.V., Reddy, B.S. and Holt, P.R. (1995) Regional chemoprevention of carcinogen-induced tumors in rat colon. Gastroenterology, 109, 1167-1172.
37. Henry, D., Lim, L.L., Garcia Rodriguez, L.A. et al. (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Br. Med. J., 312, 1563-1566.